Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins
Open accessAbstract
Transcriptional activation of HIV-1 gene expression by the viral Tat protein requires the interaction of a cellular cofactor with the Tat activation domain. This domain has been shown to consist of the cysteine-rich and core motifs of HIV-1 Tat and is functionally conserved in the distantly related Tat proteins of HIV-2 and EIAV. Using the yeast two-hybrid system, we have identified a novel human gene product, termed HT2A, that specifically and precisely binds to the activation domain of HIV-1 Tat and that can also interact with the HIV-2 and EIAV Tat proteins in vivo. We present data further demonstrating that the interaction between the activation domain of HIV-1 Tat and the HT2A protein can be readily detected in the mammalian cell nucleus. Sequence analysis demonstrates that HT2A is a novel member of the C3HC4 or ring finger family of zinc finger proteins that includes several known oncogenes and transcription factors. Overall, these data suggest that HT2A may play a significant role in mediating the biological activity of the HIV-1 Tat protein in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TRIM32, previously known as HT2A, was originally discovered using a yeast two-hybrid assay with human immunodeficiency virus type 1 Tat as bait.
“It was originally discovered using a yeast two-hybrid assay with the human immunodeficiency virus type 1 Tat acting as bait (Fridell et al. 1995; Reymond et al. 2001).”
From Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene (2002) · cites this paper as Fridell et al. 1995
Cited by
Sorted by citations
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 ( Tlr4 )
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525 · see citing works
“U18543) known to interact with the activation domain of lentiviral Tat proteins (33).”
BackgroundTRIM family proteins and their emerging roles in innate immunity
Ozato, K., Shin, D.-M., Chang, T.-H., & Morse, H. (2008) · Nature reviews. Immunology · doi:10.1038/nri2413 · Cited by 1,120 · see citing works
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761 · see citing works
“TRIM32 was shown to interact specifically with several lentiviral Tat protein”
BackgroundSlack, F. J., Basson, M., Liu, Z., Ambros, V., Horvitz, H. R., & Ruvkun, G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80245-2 · Cited by 751 · see citing works
“…Drosophila LIN-41 ortholog with high conservation in the NHL domain (48%we first recognized this domain in the NCL-1 (Frank and Roth, 1998), HT2A (Fridell et al., 1995), and LIN-41 identity; 67% similarity over 183 amino acids; TBLASTN p value 5 3 10262) as well as less dramatic but…”
BackgroundInfluentialPredicting protein–protein interactions from primary structure
Bock, J. R., & Gough, D. A. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.5.455 · Cited by 531 · see citing works
“…are a common motif, comprising, e.g. NHL repeat domains (45 a.a) found on proteins involved in mediating activity of lentiviral Tat proteins in vivo (Fridell et al., 1995), and WD40 repeat domains (40 a.a.) on G-proteins, important regulators of a host of cellular functions (Neer et al., 1994).”
BackgroundPML protein isoforms and the RBCC/TRIM motif
Jensen, K., Shiels, C., & Freemont, P. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204765 · Cited by 465 · see citing works
Chiang, A. P.-F., Beck, J. S., Yen, H.-J., Tayeh, M. K., Scheetz, T. E., Swiderski, R. E., Nishimura, D. Y., Braun, T. A., Kim, K. A., Huang, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600158103 · Cited by 433 · see citing works
<i>Drosophila</i> Brain Tumor is a translational repressor
Sonoda, J., & Wharton, R. P. (2001) · Genes & Development · doi:10.1101/gad.870801 · Cited by 329 · see citing works
“All three factors have ties to RNA metabolism: the nucleoli in Caenorhabditis elegans ncl-1 mutants are enlarged (Frank and Roth 1998); HT2A was identified by virtue of interaction with the RNAbinding protein HIV Tat (Fridell et al. 1995); and posttranscriptional regulation of lin-29 mRNA is abrogated in lin-41 mutant…”
BackgroundInfluentialTranslational Regulation and RNA Localization in Drosophila Oocytes and Embryos
Johnstone, O., & Lasko, P. F. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090756 · Cited by 322 · see citing works
“This domain has not been assigned a molecular function, but it is present in several proteins implicated in RNA processing (64, 65, 207).”
BackgroundIdentification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins
Bogerd, H. P., Fridell, R. A., Madore, S. J., & Cullen, B. R. (1995) · Cell · doi:10.1016/0092-8674(95)90437-9 · Cited by 305 · see citing works
Self-citationBraun, L., Ghebrehiwet, B., & Cossart, P. (2000) · EMBO Journal · doi:10.1093/emboj/19.7.1458 · Cited by 316 · see citing works
“…for the globular ‘heads’ of C1q, it is also able, as shown recently, to bind multiple ligands including thrombin, vitronectin, high molecular weight kininogen and the HIV-1 Tat transactivator (Fridell et al., 1995; Yu et al., 1995; Herwald et al., 1996; Joseph et al., 1996; Lim et al., 1996).”
BackgroundSardiello, M., Cairo, S., Fontanella, B., Ballabio, A., & Meroni, G. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-225 · Cited by 280 · see citing works
Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K. (2002) · The American Journal of Human Genetics · doi:10.1086/339083 · Cited by 261 · see citing works
“2 for TRIM32); the A of the initiator Met codon is considered to be nucleotide 1. b For V1, the presence or deletion of 11 bp is denoted by or , respectively; for V2 and V4, alleles are denoted by amino acid codes; and, for V3, alleles are denoted by nucleotides. prepared by amplifying a 733-bp fragment of the gene by…”
BackgroundMethodInfluentialBieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.7056 · Cited by 260 · see citing works
“Overall, there was an absolute correlation between retention of a functional activation domain, i.e. with the predicted ability of these truncated or mutant Tat proteins to bind an essential cellular cofactor (Fridell et al., 1995), and their actual ability to bind CycT1 in vivo.”
BackgroundMethodInfluentialSelf-citationCrystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein
Jiang, J., Zhang, Y., Krainer, A. R., & Xu, R.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3572 · Cited by 253 · see citing works
TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle
Uchil, P. D., Quinlan, B. D., Chan, W.-T., Luna, J. M., & Mothes, W. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040016 · Cited by 241 · see citing works
“TRIM22 and TRIM32 were reported to attenuate transcription of the HIV LTR [25,26].”
InfluentialMuta, T., Kang, D., Kitajima, S., Fujiwara, T., & Hamasaki, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24363 · Cited by 232 · see citing works
Kudryashova, E., Kudryashov, D. S., Kramerova, I. A., & Spencer, M. J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.068 · Cited by 207 · see citing works
TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation
Napolitano, L. M. R., & Meroni, G. (2011) · IUBMB Life · doi:10.1002/iub.580 · Cited by 174 · see citing works
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7791 · Cited by 172 · see citing works
Self-citationTwo B or not two B? overview of the rapidly expanding B-box family of proteins
Torok, M., & Etkin, L. D. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.067003063.x · Cited by 169 · see citing works
TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase
Fu, B., Wang, L., Ding, H., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004960 · Cited by 163 · see citing works
“In fact TRIM32 was among the first TRIMs shown to specifically interact with a viral protein, tat [9].”
BackgroundA novel repeat domain that is often associated with RING finger and B-box motifs
Slack, F. J., & Ruvkun, G. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01299-7 · Cited by 151 · see citing works
Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat
Chun, R. F., Semmes, O. J., Neuveut, C., & Jeang, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2615-2629.1998 · Cited by 151 · see citing works
“These proteins include TATA-binding protein (TBP) (65, 104), TAK (43, 44), PKR (8, 79), T3R (21), Tat-binding protein 1 (83, 84), TAP (20, 111, 112), TBP-associated factor TAF55 (11), HT2A (28), Tip60 (62), TFIIH (30, 87), RNA polymerase II (77), and Sp1 (18, 54).”
The 10 autosomal recessive limb-girdle muscular dystrophies
Zatz, M., Paula, F., Starling, A., & Vainzof, M. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00100-7 · Cited by 148 · see citing works
“[97] Fridell RA, Harding LS, Bogerd HP, Cullen BR.”
BackgroundCambiaghi, V., Giuliani, V., Lombardi, S., Marinelli, C., Toffalorio, F., & Pelicci, P. G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5398-7_6 · Cited by 146 · see citing works
Arama, E., Dickman, D., Kimchie, Z., Shearn, A., & Lev, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203706 · Cited by 130 · see citing works
“4, a nematode ORF with unknown function, and the human HT2A protein, identi®ed through its interaction with the human immunode®ciency virus protein Tat (Fridell et al., 1995).”
BackgroundKano, S., Miyajima, N., Fukuda, S., & Hatakeyama, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6231 · Cited by 127 · see citing works
Horn, E. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh003 · Cited by 126 · see citing works
“The NHL domain in human TRIM32 is responsible for TAT protein interaction ( 18 ) and is mutated in LGMD2H from aspartic acid to asparagine at amino acid 487 (3).”
BackgroundThe Regulation of Human Immunodeficiency Virus Type‐1 Gene Expression
Kingsman, S. M., & Kingsman, A. J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0491h.x · Cited by 122 · see citing works
Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component
Kudryashova, E., Wu, J., Havton, L. A., & Spencer, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp036 · Cited by 117 · see citing works
Hsieh, J., Liu, J., Kostas, S. A., Chang, C., Sternberg, P. W., & Fire, A. Z. (1999) · Genes & Development · doi:10.1101/gad.13.22.2958 · Cited by 109 · see citing works
Saccone, V., Palmieri, M., Passamano, L., Piluso, G., Meroni, G., Politano, L., & Nigro, V. (2007) · Human Mutation · doi:10.1002/humu.20633 · Cited by 107 · see citing works
“TRIM32 [Fridell et al., 1995] is a ubiquitously expressed protein that belongs to a family known as TRIM or RBCC [Reymond et al.”
BackgroundNikolakaki, E., Simos, G., Georgatos, S. D., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8365 · Cited by 104 · see citing works
“As p32/p34 interacts with the HIV-1 products Rev and Tat (Luo et al., 1994; Fridell et al., 1995), it is also possible that p32/p34 may affect the properties of viral transcriptional and splicing regulators.”
BackgroundSuñé, C., Hayashi, T., Liu, Y., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.6029 · Cited by 98 · see citing works
“Other cellular factors that interact with Tat have been identified and characterized in some detail (20, 29, 32, 53, 65, 75), but none of these proteins has been conclusively shown to play a role in Tat function.”
BackgroundTRIM-NHL proteins in development and disease
Tocchini, C., & Ciosk, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.017 · Cited by 92 · see citing works
Tange, T. Ø., Jensen, T. H., & Kjems, J. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10066 · Cited by 91 · see citing works
Unique features of TRIM5α among closely related human TRIM family members
Li, X., Gold, B., Ó’hUigín, C., Diaz‐Griffero, F., Song, B., Si, Z., Li, Y., Yuan, W., Stremlau, M. H., Mische, C. C., et al. (2006) · Virology · doi:10.1016/j.virol.2006.10.035 · Cited by 88 · see citing works
MicroRNA-155 Reinforces HIV Latency
Ruelas, D. S., Chan, J. K., Oh, E., Heidersbach, A. J., Hebbeler, A. M., Chávez, L., Verdin, E. M., Rapé, M., & Greene, W. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641837 · Cited by 84 · see citing works
“TRIM32 Promotes Reactivation of Latent HIV-1 by Stimulating NF- B Signaling—TRIM32 has been reported to interact with the activation domain of HIV-1, HIV-2, and equine infectious anemia virus Tat proteins (21).”
BackgroundResultInfluentialPage, S. L., McKim, K. S., Deneen, B., et al. (2000) · Genetics · doi:10.1093/genetics/155.4.1757 · Cited by 83 · see citing works
Cloning and Characterization of a Novel RING Finger Protein That Interacts with Class V Myosins
El-Husseini, A., & Vincent, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19771 · Cited by 83 · see citing works
Structure and Function of gC1q-R: a Multiligand Binding Cellular Protein
Ghebrehiwet, B., & Peerschke, E. I. B. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80029-6 · Cited by 80 · see citing works
A cofactor, TIP30, specifically enhances HIV-1 Tatactivated transcription
Xiao, H., Tao, Y., Greenblatt, J., & Roeder, R. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2146 · Cited by 76 · see citing works
Vallejos, M., Deforges, J., Plank, T.-D., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr189 · Cited by 75 · see citing works
Mitotic Phosphorylation of the Lamin B Receptor by a Serine/Arginine Kinase and p34
Nikolakaki, E., Meier, J., Simos, G., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6208 · Cited by 75 · see citing works
Emerging RNA-binding roles in the TRIM family of ubiquitin ligases
Williams, F. P., Haubrich, K., Perez-Borrajero, C., & Hennig, J. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0158 · Cited by 70 · see citing works
“RNA related functions have long been known for certain TRIM proteins (Fridell et al., 1995; Frank and Roth, 1998; Slack et al., 2000; Sonoda and Wharton, 2001) with the C-terminal domain playing a key role in these interactions (Sonoda and Wharton, 2001; Loedige et al.”
BackgroundVerhoef, K., Koper, M., & Berkhout, B. (1997) · Virology · doi:10.1006/viro.1997.8786 · Cited by 68 · see citing works
Micale, L., Chaignat, E., Fusco, C., Reymond, A., & Merla, G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5398-7_2 · Cited by 61 · see citing works
Cao, W., & García-Blanco, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20629 · Cited by 56 · see citing works
Liu, Y., Li, J., Kim, B. O., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200773200 · Cited by 54 · see citing works
The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs
Nicklas, S., Okawa, S., Hillje, A., González-Cano, L., del Sol, A., & Schwamborn, J. C. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv138 · Cited by 54 · see citing works
“Nevertheless, the quality of our mass spectrometry approach is supported by the detection of several previously reported TRIM32 interaction partners, including (cid:4) -actinin and tropomyosin-1 (cid:4) (45), myosin (46), HIV Tat (47) as well as UBE2N and UBE2V1 (29) (Supplementary Table S1).”
Ins and outs of therapy in limb girdle muscular dystrophies
Danièle, N., Richard, I., & Bartoli, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.005 · Cited by 53 · see citing works
Limb-girdle muscular dystrophy 2H and the role of TRIM32
Shieh, P. B., Kudryashova, E., & Spencer, M. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-08-045031-5.00009-8 · Cited by 52 · see citing works
“Initial studies of TRIM32 showed that it bound to the human immunodeficiency virus (HIV) Tat protein by yeast two-hybrid analysis (Fridell et al., 1995), and in a separate study that TRIM32 was upregulated in skin cancer cells with antiapoptotic properties (Horn et al.”
BackgroundThe autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein
Reef, S., Shifman, O., Oren, M., & Kimchi, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210485 · Cited by 51 · see citing works
“…Simos and Georgatos, 1994; Yu et al., 1995a; Deb and Datta, 1996; Herwald et al., 1996; Lim et al., 1996) and viral proteins (Desai et al., 1991; Luo et al., 1994; Fridell et al., 1995; Yu et al., 1995b; Bruni and Roizman, 1996; Tange et al., 1996; Wang et al., 1997; Matthews and Russell, 1998).”
BackgroundBlair, W. S., Parsley, T. B., Bogerd, H. P., et al. (1998) · PubMed · Cited by 48 · see citing works
Self-citationTripartite motif 32 prevents pathological cardiac hypertrophy
Chen, L., Huang, J., Ji, Y., Zhang, X., Wang, P., Deng, K., Jiang, X., Ma, G., & Li, H. (2016) · Clinical Science · doi:10.1042/cs20150619 · Cited by 45 · see citing works
TRIMming p53’s anticancer activity
Elabd, S., Meroni, G., & Blattner, C. (2016) · Oncogene · doi:10.1038/onc.2016.33 · Cited by 43 · see citing works
Nuclear functions of endocytic proteins
Pilecka, I., Banach‐Orlowska, M., & Miączyńska, M. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2007.04.004 · Cited by 43 · see citing works
Molecular bases of autosomal recessive limb-girdle muscular dystrophies.
Nigro, V. (2003) · PubMed · Cited by 42 · see citing works
BERP, a Novel Ring Finger Protein, Binds to α-Actinin-4
El-Husseini, A., Kwasnicka, D. A., Yamada, T., Hirohashi, S., & Vincent, S. R. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2045 · Cited by 42 · see citing works
Recent insights into host–pathogen interaction in white spot syndrome virus infected penaeid shrimp
Shekhar, M. S., & Ponniah, A. G. (2014) · Journal of Fish Diseases · doi:10.1111/jfd.12279 · Cited by 40 · see citing works
TRIM32-dependent transcription in adult neural progenitor cells regulates neuronal differentiation
Hillje, A., Pavlou, M. A. S., Beckmann, E., Worlitzer, M. M. A., Bahnassawy, L., Lewejohann, L., Palm, T., & Schwamborn, J. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.487 · Cited by 40 · see citing works
“and to interact with the activation domain of lentiviral Tat proteins.(19) Interestingly, a similar nuclear translocation to induce differentiation has been shown for other tumorsuppressor proteins, such as PTEN.”
BackgroundHighly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4592 · Cited by 38 · see citing works
“and GST-eTat expression plasmids have been previously described (12).”
BackgroundSelf-citationIchimura, T., Taoka, M., Shoji, I., Kato, H., Sato, T. Z., Hatakeyama, S., Isobe, T., & Hachiya, N. (2013) · Journal of Cell Science · doi:10.1242/jcs.122069 · Cited by 35 · see citing works
“TRIM32 is ubiquitously expressed in mammalian tissues, but the level varies depending on cell type and conditions (Fridell et al., 1995; Frosk et al., 2002; Horn et al., 2004; Kano et al., 2008).”
BackgroundBawa, S., Piccirillo, R., & Geisbrecht, E. R. (2021) · Biomolecules · doi:10.3390/biom11030408 · Cited by 34 · see citing works
“One of these TRIM-NHL proteins, TRIM32, was uncovered as a protein that binds to HIV-1 Tat, a key transactivator of viral transcription [6].”
BackgroundBlair, W. S., Fridell, R. A., & Cullen, B. R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00511.x · Cited by 33 · see citing works
Self-citationWulczyn, F. G., Cuevas, E., Franzoni, E., et al. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7823-3_9 · Cited by 31 · see citing works
Fatima, M., Kumari, R., Schwamborn, J. C., Mahadevan, A., Shankar, S. K., Raja, R., & Seth, P. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.138 · Cited by 31 · see citing works
Inhibition of retroviral replication by members of the TRIM protein family.
Fletcher, A. J., & Towers, G. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-37765-5_2 · Cited by 35 · see citing works
“TRIM32 was identified by yeast two-hybrid as a binding partner of HIV-1 Tat (Fridell et al. 1995) and has since been shown to target STING/MITA, the signal adaptor, for K63-linked”
BackgroundOrsini, M., & Debouck, C. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8055-8063.1996 · Cited by 31 · see citing works
“Recently, a cellular factor containing a zinc finger domain and homology to several oncogenes and transcription factors that interacts with Tat through both the core and cysteine-rich domains was identified (18).”
BackgroundGoyani, S., Roy, M., & Singh, R. K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166066 · Cited by 30 · see citing works
Epithelin/Granulin Growth Factors: Extracellular Cofactors for HIV-1 and HIV-2 Tat Proteins
Trinh, D. P., Brown, K. M., & Jeang, K.-T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0317 · Cited by 29 · see citing works
Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis
Liu, Y., Wang, Z., Torre, R. D. L., Barling, A. N., Tsujikawa, T., Hornick, N. I., Hanifin, J. M., Simpson, E. L., Wang, Y., Swanzey, E., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.020 · Cited by 28 · see citing works
“…to innate immunity by (1) restricting viral replication (Fu et al., 2015; Uchil et al., 2008), (2) inhibiting viral protein activity (Fatima et al., 2016; Fridell et al., 1995), and (3) activating innate immune signaling pathways (Albor et al., 2006; Uchil et al., 2013; Zhang et al., 2012).”
Woodsmith, J., Jenn, R. C., & Sanderson, C. M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016162 · Cited by 28 · see citing works
El-Husseini, A., Fretier, P., & Vincent, S. R. (2001) · Genomics · doi:10.1006/geno.2000.6452 · Cited by 27 · see citing works
Holloway, A. F., Occhiodoro, F., Mittler, G., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909058199 · Cited by 27 · see citing works
Role of Divalent Cations in HIV-1 Replication and Pathogenicity
Khan, N., Chen, X., & Geiger, J. D. (2020) · Viruses · doi:10.3390/v12040471 · Cited by 26 · see citing works
Different subcellular localisations of TRIM22 suggest species-specific function
Herr, A.-M., Dressel, R., & Walter, L. (2009) · Immunogenetics · doi:10.1007/s00251-009-0357-z · Cited by 24 · see citing works
“2006) and TRIM32 interacts with tat proteins of HIV-1 and HIV-2 (Fridell et al. 1995).”
BackgroundKim, H., Choi, B., Kim, S. S., Roh, T., Park, J., & Yoon, C. (2014) · Retrovirology · doi:10.1186/s12977-014-0067-y · Cited by 23 · see citing works
“Although it has also been reported that Tat activity is modulated by Tat-interacting proteins such as Tip60, HT2A, CA150, TFIID, Tat-SF1, Tip30, p300, CREB-binding protein, PC4, and Tip110, which regulate Tat activity by regulating its interactions with TAR RNA and/or other host factors [10-20], the precise mechanisms…”
BackgroundIto, M., Migita, K., Matsumoto, S., Wakatsuki, K., Tanaka, T., Kunishige, T., Nakade, H., Nakatani, M., & Nakajima, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5806 · Cited by 24 · see citing works
Li, L., Feng, W., Cheng, Z., et al. (2019) · Poultry Science · doi:10.3382/ps/pez408 · Cited by 22 · see citing works
Interaction of Sp1 transcription factor with HIV‐1 Tat protein: looking for cellular partners
Loregian, A., Bortolozzo, K., Boso, S., Caputo, A., & Palù, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00399-5 · Cited by 22 · see citing works
Kajaste‐Rudnitski, A., Pultrone, C., Marzetta, F., Ghezzi, S., Coradin, T., & Vicenzi, E. (2009) · Amino Acids · doi:10.1007/s00726-009-0393-x · Cited by 21 · see citing works
“TRIM32 HIV-1, HIV-2 and EIAV Tat Transcription regulation Fridell et al. (1995) TRIM34 SIV CA Weak restriction activity Li et al. (2007),”
BackgroundThe Sp1 transcription factor does not directly interact with the HIV‐1 Tat protein
Loregian, A., Bortolozzo, K., Boso, S., et al. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10271 · Cited by 21 · see citing works
“A number of cellular proteins have been reported to interact with Tat, including Tatbinding protein 1 (Nelbock et al., 1990), TBP (Kashanchi et al., 1994), TBP-associated factor TAFII55 (Chiang and Roeder, 1995), HT2A (Fridell et al., 1995), Tip60 (Kamine et al., 1996), cyclin T1 (Wei et al., 1998), Puralpha (Gallia e…”
Anti-HIV-1 activity of Trim 37
Tabah, A. A., Tardif, K. D., & Mansky, L. M. (2013) · Journal of General Virology · doi:10.1099/vir.0.057653-0 · Cited by 19 · see citing works
Blair, W. S., & Cullen, B. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2888 · Cited by 19 · see citing works
“pBS/b-GAL was generated by digestion of pCMV/b-GAL (11) with EcoRI and”
MethodSelf-citationInhibition of the HIV Rev transactivator A new target for therapeutic intervention
Heguy, A. (1997) · Frontiers in bioscience · doi:10.2741/a191 · Cited by 19 · see citing works
“A hammerhead ribozyme targeting the common exon of the Tat and Rev genes has been shown to inhibit HIV replication in a human T cell line (84).”
BackgroundInfluentialLentiviral Effector Pathways of TRIM Proteins
Turrini, F., Pietro, A. D., & Vicenzi, E. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2374 · Cited by 17 · see citing works
TRIM Proteins and the Innate Immune Response to Viruses
Yap, M. W., & Stoye, J. P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5398-7_7 · Cited by 18 · see citing works
RNAs selected in vitro by the HIV-2 tat protein
Rhim, H., & Rice, A. P. (1997) · Journal of Biomedical Science · doi:10.1007/bf02255590 · Cited by 18 · see citing works
“Candidates for cellular factors that may mediate the Tat activation domain function have been identified, including TBP [18], TAP [35], Tip60 [16], and HT2A [ 10 ].”
Backgroundp32 is a negative regulator of p53 tetramerization and transactivation
Ghate, N. B., Kim, J., Shin, Y., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12543 · Cited by 17 · see citing works
“…protein V of adenovirus, ORF P of herpes simplex virus, EBNA-1 of Epstein–Barr virus, and HIV-1 Tat and Rev (Bruni and Roizman, 1996; Desai et al., 1991; Fridell et al., 1995; Luo et al., 1994; Matthews and Russell, 1998; Tange et al., 1996; Wang et al., 1997; Yu et al., 1995; Yu et al., 1995).”
BackgroundGammaherpesvirus maintenance and replication during latency
Lieberman, P. M., Hu, J., & Renne, R. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.025 · Cited by 16 · see citing works
Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
Jeong, S. Y., Choi, J. H., Kim, J., Woo, J. S., & Lee, E. H. (2023) · Cells · doi:10.3390/cells12162104 · Cited by 14 · see citing works
“TRIM32 in skeletal muscle gained attention almost ten years after it was identified as a Tat-binding protein [2,57].”
BackgroundMethodMiyamoto, K., Nakamura, N., Kashiwagi, M., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03332.x · Cited by 15 · see citing works
Two-hybrid systems and their usage in infection biology
Karimova, G., Ladant, D., & Ullmann, A. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00182 · Cited by 14 · see citing works
Enhancement of the Basal-Level Activity of HIV-1 Long Terminal Repeat by HIV-1 Nucleocapsid Protein
Zhang, J. L., Sharma, P. L., & Crumpacker, C. S. (2000) · Virology · doi:10.1006/viro.2000.0194 · Cited by 14 · see citing works
Xie, Y., Cao, J., Gan, S., Xu, L.-D., Zhang, D., Qian, S., Xu, F., Ding, Q., Schoggins, J. W., & Fan, W. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012312 · Cited by 12 · see citing works
Li, L., Zhuang, P., Cheng, Z., et al. (2020) · Journal of Veterinary Science · doi:10.4142/jvs.2020.21.e49 · Cited by 11 · see citing works
“RING domain E3 ubiquitin ligase has been associated with the antiviral activity of the TRIM protein [20,21].”
BackgroundLiu, L., Liu, T., Xie, G., Zhu, X., & Wang, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100031rr · Cited by 11 · see citing works
Inverse Correlation of TRIM32 and Protein Kinase C ζ in T Helper Type 2–Biased Inflammation
Wang, Z., Yoo, Y. J., Torre, R. D. L., Topham, C. A., Hanifin, J. M., Simpson, E. L., Messing, R. O., Kulesz-Martin, M. F., & Liu, Y. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.09.021 · Cited by 10 · see citing works
- Authors
- Fridell, R. A., Harding, L. S., Bogerd, H. P., & Cullen, B. R.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 209
- Issue
- 2
- Pages
- 347-357
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1972407993
- Cited by
- 129
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 5
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV-1 Tat protein, zinc finger proteins, transcriptional activation, protein-protein interaction, HIV-1 gene expression, nuclear protein binding
- MeSH terms
- Tripartite Motif Proteins, Amino Acid Sequence, Animals, Binding Sites, Cell Line, Cell Nucleus, Chlorocebus aethiops, HeLa Cells, Humans, Kidney, Molecular Sequence Data, Recombinant Proteins, Transcription Factors, Transfection, HIV-1, HIV-2, Chloramphenicol O-Acetyltransferase, Gene Products, tat, Zinc Fingers, Sequence Homology, Amino Acid, DNA, Complementary, Ubiquitin-Protein Ligases, tat Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review